Advertisement

Related Videos

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Advertisement

Advertisement




Jan
08
Today In Oncology
Using AI to Ensure That All Patients With Cancer Have Access to Precision Oncology Care
AI Enhances Detection of Missed Breast Cancers on Screening Tomosynthesis
Hybrid AI Approach With Uncertainty Quantification for Mammography Reading Supports Safe Workload Reduction
AI May Boost Efficacy of Cancer Care but Physicians Remain Critical to Decision Making
Novel AI Platform May Help Identify Patients Likely to Benefit Most From Clinical Trials
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo